COMPACT BIO ENERGY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
COMPACT BIO ENERGY
Largest movements
- Cash -€1,305
down €1,305 (-64.9%), from €2,012 to €707
mainly Trade debts (-€7,811) and Net result for the year (-€6,571)
- Receivables within one year -€1,178
down €1,178 (-10.4%), from €11,361 to €10,183
of which Trade receivables: -€1,655
- Other debts +€12,341
up €12,341 (+287%), from €4,297 to €16,638
- Trade debts -€7,811
down €7,811 (-1.4%), from €555,230 to €547,419
- Profit (loss) carried forward -€6,571
down €6,571 (-0.4%), from -€1.6m to -€1.6m
- Gross operating margin +€1,675
up €1,675 (+24.1%), from -€6,945 to -€5,269
- Other operating charges +€695
up €695 (+115%), from €605 to €1,300
- Staff costs -€284
no longer reported in 2026 (was €284)
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €61,059 | €59,018 | -€2,041 | -3.3% |
| Fixed assets | 21/28 | €1,170 | €1,328 | +€158 | +13.5% |
| Financial fixed assets | 28 | €1,170 | €1,328 | +€158 | +13.5% |
| Current assets | 29/58 | €59,889 | €57,690 | -€2,199 | -3.7% |
| Amounts receivable within one year | 40/41 | €11,361 | €10,183 | -€1,178 | -10.4% |
| Trade receivables | 40 | €1,736 | €81 | -€1,655 | -95.3% |
| Other amounts receivable | 41 | €9,625 | €10,102 | +€477 | +5.0% |
| Cash at bank and in hand | 54/58 | €2,012 | €707 | -€1,305 | -64.9% |
| Deferred charges and accrued income | 490/1 | €46,517 | €46,800 | +€284 | +0.6% |
| Total equity and liabilities | 10/49 | €61,059 | €59,018 | -€2,041 | -3.3% |
| Equity | 10/15 | -€502,559 | -€509,130 | -€6,571 | -1.3% |
| Contributions | 10/11 | €363,600 | €363,600 | = | 0.0% |
| Reserves | 13 | €776,147 | €776,147 | = | 0.0% |
| Non-distributable reserves | 130/1 | €36,219 | €36,219 | = | 0.0% |
| Reserves not available under the articles | 1311 | €36,219 | €36,219 | = | 0.0% |
| Tax-exempt reserves | 132 | €739,928 | €739,928 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€1,642,307 | -€1,648,878 | -€6,571 | -0.4% |
| Amounts payable | 17/49 | €563,618 | €568,148 | +€4,530 | +0.8% |
| Amounts payable within one year | 42/48 | €559,527 | €564,057 | +€4,530 | +0.8% |
| Trade debts | 44 | €555,230 | €547,419 | -€7,811 | -1.4% |
| Suppliers | 440/4 | €555,230 | €547,419 | -€7,811 | -1.4% |
| Other amounts payable | 47/48 | €4,297 | €16,638 | +€12,341 | +287% |
| Accrued charges and deferred income | 492/3 | €4,091 | €4,091 | = | 0.0% |
| Remuneration, social security and pensions | 62 | €284 | - | -€284 | |
| Other operating charges | 640/8 | €605 | €1,300 | +€695 | +115% |
| Gross operating margin | 9900 | -€6,945 | -€5,269 | +€1,675 | +24.1% |
| Operating profit (loss) | 9901 | -€7,833 | -€6,569 | +€1,264 | +16.1% |
| Financial income | 75/76B | €1 | - | -€1 | |
| Recurring financial income | 75 | €1 | - | -€1 | |
| Financial charges | 65/66B | €1 | €2 | +€1 | +49.5% |
| Recurring financial charges | 65 | €1 | €2 | +€1 | +49.5% |
| Profit (loss) for the period before taxes | 9903 | -€7,833 | -€6,571 | +€1,262 | +16.1% |
| Profit (loss) for the period | 9904 | -€7,833 | -€6,571 | +€1,262 | +16.1% |
| Profit (loss) for the period to be appropriated | 9905 | -€7,833 | -€6,571 | +€1,262 | +16.1% |
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.